Clinical Trial

Dexamethasone in Tick-borne Encephalitis

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the efficacy of dexamethasone in patients with tick-borne encephalitis.
Trial Details
NCT Number NCT07584525
Lead Sponsor University Medical Centre Ljubljana
Conditions Tick-Borne Encephalitis
Enrollment 200 participants
Start Date 2024-05-03
Primary Completion 2030-09-30 (estimated)
Study Completion 2030-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-13